Pre-Made Opinercept Biosimilar, Fusion Protein targeting TNF fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting DIF/TNFSF2/TNLG1F is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Opinercept is a tumor necrosis factor receptor superfamily protein TNFRSF1B (human extracellular domain fragment) fusion protein with immunoglobulin G1 (human FC fragment) that sequesters extracellular TNF-¦Á to decrease signal transduction, which has been used for the rheumatoid arthritis treatment.